Bio-Rad Laboratories, Inc. (NYSE:BIO) Q4 2023 Earnings Call Transcript February 15, 2024
Bio-Rad Laboratories, Inc. beats earnings expectations. Reported EPS is $3.1, expectations were $2.93. BIO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Good afternoon, ladies and gentlemen. And welcome to the Bio-Rad Fourth Quarter and Full Year 2023 Earnings Results Conference Call. At this time, all lines are in a...
